Waldron Private Wealth LLC Sells 235 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Waldron Private Wealth LLC lessened its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 10.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,106 shares of the medical equipment provider’s stock after selling 235 shares during the quarter. Waldron Private Wealth LLC’s holdings in Intuitive Surgical were worth $710,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in ISRG. OFI Invest Asset Management purchased a new stake in Intuitive Surgical in the third quarter worth $25,000. Baystate Wealth Management LLC grew its stake in Intuitive Surgical by 150.0% in the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 45 shares during the period. Headinvest LLC purchased a new stake in Intuitive Surgical in the third quarter worth $28,000. Stone House Investment Management LLC grew its stake in Intuitive Surgical by 100.0% in the third quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 50 shares during the period. Finally, Householder Group Estate & Retirement Specialist LLC purchased a new stake in Intuitive Surgical in the third quarter worth $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Trading Up 0.6 %

ISRG stock traded up $2.46 during trading on Monday, reaching $387.26. The stock had a trading volume of 215,867 shares, compared to its average volume of 1,615,805. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $403.76. The stock’s 50 day moving average is $388.26 and its two-hundred day moving average is $340.99. The firm has a market cap of $137.26 billion, a PE ratio of 76.94, a PEG ratio of 5.97 and a beta of 1.36.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, January 23rd. The medical equipment provider reported $1.60 earnings per share for the quarter, beating analysts’ consensus estimates of $1.48 by $0.12. Intuitive Surgical had a return on equity of 13.11% and a net margin of 25.24%. The company had revenue of $1.93 billion for the quarter, compared to the consensus estimate of $1.89 billion. During the same quarter in the prior year, the company earned $0.91 earnings per share. Intuitive Surgical’s revenue was up 16.6% on a year-over-year basis. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 4.93 EPS for the current year.

Insider Activity

In other news, VP Marshall Mohr sold 108,790 shares of Intuitive Surgical stock in a transaction dated Wednesday, February 28th. The stock was sold at an average price of $385.08, for a total transaction of $41,892,853.20. Following the transaction, the vice president now directly owns 26,877 shares of the company’s stock, valued at approximately $10,349,795.16. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, VP Marshall Mohr sold 108,790 shares of Intuitive Surgical stock in a transaction dated Wednesday, February 28th. The stock was sold at an average price of $385.08, for a total transaction of $41,892,853.20. Following the transaction, the vice president now directly owns 26,877 shares of the company’s stock, valued at approximately $10,349,795.16. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, President David J. Rosa sold 80,710 shares of Intuitive Surgical stock in a transaction dated Wednesday, February 7th. The shares were sold at an average price of $389.28, for a total value of $31,418,788.80. Following the transaction, the president now directly owns 163,399 shares in the company, valued at $63,607,962.72. The disclosure for this sale can be found here. Insiders have sold a total of 248,418 shares of company stock valued at $95,927,097 in the last ninety days. Corporate insiders own 0.80% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on ISRG shares. Citigroup upped their price target on Intuitive Surgical from $428.00 to $462.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd. Barclays increased their target price on Intuitive Surgical from $385.00 to $430.00 and gave the stock an “overweight” rating in a research note on Thursday, January 25th. Royal Bank of Canada increased their target price on Intuitive Surgical from $400.00 to $432.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 24th. Piper Sandler increased their target price on Intuitive Surgical from $325.00 to $425.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 24th. Finally, Truist Financial increased their target price on Intuitive Surgical from $390.00 to $435.00 and gave the stock a “buy” rating in a research note on Wednesday, January 24th. Five investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $375.70.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.